Success Metrics

Active Trials
1(50%)

Phase Distribution

Ph not_applicable
1
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

2

all time

Status Distribution
Active(2)

Detailed Status

Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
2
Active
1
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

recruiting150%
not_yet_recruiting150%

Recent Activity

1 active trials
Showing 2 of 2
not_yet_recruitingnot_applicable

Trial of Routine Abdominal Wall Closure Versus Reinforcement With TIGR Matrix Onlay

NCT02487134
recruiting

Post-market Surveillance Study to Evaluate the Quality of Life and the Safety and Effectiveness of the TIGR® Matrix After Reconstructive Breast Surgery

NCT06511167

Clinical Trials (2)

Showing 2 of 2 trials
NCT02487134Not Applicable

Trial of Routine Abdominal Wall Closure Versus Reinforcement With TIGR Matrix Onlay

Not Yet Recruiting
NCT06511167

Post-market Surveillance Study to Evaluate the Quality of Life and the Safety and Effectiveness of the TIGR® Matrix After Reconstructive Breast Surgery

Recruiting

All 2 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
2